Personalised Medicine
Basel Forum 2011
This Adelphi hosted event, entitled "Personalised medicine; moving from promise to practice" provocatively asked "Is it all about new science, or is there more to the Personalised Medicine story"
Led by an impressive faculty of experts and chaired by Adelphi CEO Stuart Cooper, the forum explored the intricacies of strategy, practice and political conundrums resident within the European context.
Stuart Cooper
CEO of the Adelphi Group, and meeting chairman
Modern medicine and the drug development process have long been directed by the law of averages — aimed at greatest effect across the largest number of…
Jerry Coamey
SVP and Practice Leader of Personalised Healthcare for CAHG
…advocated engagement with physicians and the public as an essential strand of Personalised Medicine strategy to help these critical customers in accelerating its adoption into clinical…
Jayne C. Fox
Principal Scientist, AstraZeneca, Genetics Advisor within Personalised Healthcare and Biomarkers function
Expression of Strategic Intent
The AstraZeneca strapline: "Bringing the right medicine, to the right patient at the right time" embodies the corporate philosophy and strategy…
read more about Jayne C. Fox's 'Embracing the immediate challenges'
Dr Detlef Niese
Head of External Affairs, Global Development, Novartis Pharma AG
Inherent Flaws in the System
We currently diagnose diseases based on common criteria, often using imprecise tools; we treat according to guidelines designed for populations…
read more about Dr Detlef Niese's 'Changing paradigms for drug development'
Richard Sterneberg
European lobbyist, EU regulatory issues & disease awareness campaigns, Associate G+Europe
Current Policy Agenda
“Personalised Medicine” has hit the EU agenda, with high-level debate on appropriate involvement versus other
investments in public health. Issues include:
read more about Richard Sterneberg's 'The EU policy perspective'
Rob Dhoble
President of DAS Healthcare, leads the specialised global healthcare
Leveraging Systems to Inform Prescription
Continuous knowledge capture around medication use on a large scale, in particular by registries, can help to inform the ideal…
read more about Rob Dhoble's 'The role of digital assets in personalised engagement'